Dror Bashan - Net Worth and Insider Trading
Dror Bashan Net Worth
The estimated net worth of Dror Bashan is at least $152,393 dollars as of 2024-04-27. Dror Bashan is the PRESIDENT AND CEO of Protalix BioTherapeutics Inc and owns about 132,516 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $152,393. Details can be seen in Dror Bashan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dror Bashan has not made any transactions after 2023-10-19 and currently still holds the listed stock(s).
Transaction Summary of Dror Bashan
Dror Bashan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dror Bashan owns 1 companies in total, including Protalix BioTherapeutics Inc (PLX) .
Click here to see the complete history of Dror Bashan’s form 4 insider trades.
Insider Ownership Summary of Dror Bashan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2023-10-19 | director & President and CEO |
Dror Bashan Latest Holdings Summary
Dror Bashan currently owns a total of 1 stock. Dror Bashan owns 132,516 shares of Protalix BioTherapeutics Inc (PLX) as of October 19, 2023, with a value of $152,393.
Latest Holdings of Dror Bashan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2023-10-19 | 132,516 | 1.15 | 152,393 |
Holding Weightings of Dror Bashan
Dror Bashan Form 4 Trading Tracker
According to the SEC Form 4 filings, Dror Bashan has made a total of 2 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Protalix BioTherapeutics Inc is the acquisition of 64,516 shares on October 19, 2023, which cost Dror Bashan around $90,322.
Insider Trading History of Dror Bashan
- 1
Dror Bashan Trading Performance
GuruFocus tracks the stock performance after each of Dror Bashan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dror Bashan is -9.11%. GuruFocus also compares Dror Bashan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dror Bashan within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dror Bashan's insider trading performs compared to the benchmark.
Performance of Dror Bashan
Average Return
66.67%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.18 | -9.11 | -24.41 | 66.67 | -6.97 | |
| Relative Return to S&P 500(%) | -12.53 | -9.35 | -23.13 | 73.55 | -15.51 |
Dror Bashan Ownership Network
Ownership Network List of Dror Bashan
Ownership Network Relation of Dror Bashan
Dror Bashan Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
Dror Bashan is the director & President and CEO of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include 10 percent owner Dexcel Pharma Technologies Ltd. , 10 percent owner Dan Oren , and Sr. VP and CFO Eyal Rubin .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, Dror Bashan made 1 insider transaction in Protalix BioTherapeutics Inc (PLX) with a net purchase of 64,516. Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 110,000 shares made by Aharon Schwartz ,
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 174,516 shares were bought by its insiders, resulting in a net purchase of 174,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
Dror Bashan Mailing Address
Above is the net worth, insider trading, and ownership report for Dror Bashan. You might contact Dror Bashan via mailing address: 2 Snunit St, Science Park, Pob 455, Carmiel L3 L3 20100.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
